search
Back to results

Diabetes Education With Real-time Continuous Glucose Monitoring (CUTDM)

Primary Purpose

Diabetes Type 2

Status
Recruiting
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Dexcom G6
Sponsored by
University of Washington
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Diabetes Type 2 focused on measuring continuous glucose monitoring, diabetes education

Eligibility Criteria

18 Years - 60 Years (Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  1. Participants adults 18-55 years old
  2. Self-identify as Latinx
  3. Have had a clinical diagnosis of T2D within the last 5 years with or without medication use
  4. Have an A1C ≥8.0% at screening
  5. Own or have routine access to a personal device that allows attending educational sessions virtually
  6. Be physically and cognitively able to use the home CGM monitoring device
  7. Be willing and able to follow all other study procedures

Exclusion Criteria

  • Exclusion Criteria.

    1. Duration of diabetes >5 years
    2. Type 1 diabetes or latent autoimmune diabetes
    3. Current use of prandial insulin
    4. Any condition that prevents walking at least 1 city block
    5. History of serious mental illness other than adequately treated depression
    6. History of bariatric surgery or current participation in a weight management program
    7. Current diagnosis of cancer or other serious or systemic medical condition
    8. Significant active cardio- or cerebrovascular disease after review by PI
    9. Pregnancy
    10. Unable to read, understand, and sign the Informed Consent Form (ICF) and if applicable, an Authorization to Use and Disclose Protected Health Information form (consistent with Health Insurance Portability and Accountability Act of 1996 [HIPAA] legislation), communicate with the investigator, and understand and comply with protocol requirements

Sites / Locations

  • University of Washington Diabetes InstituteRecruiting
  • University of WashingtonRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

No Intervention

Arm Label

CGM with DM education

Education only

Arm Description

if you are in the intervention group you will received culturally tailored diabetes education and use a Real Time CGM device to see your glucose over 12 weeks. Both group will completed blinded CGM at the beginning of the study and at 24 weeks

If you are in the control group your will receive culturally tailored diabetes education and wear a blinded prior to education and after education sessions complete and 24 weeks

Outcomes

Primary Outcome Measures

A1C
average glucose over 3 months

Secondary Outcome Measures

CGM mean glucose
mean glucose
CGM percent time in range
percent time in range( tir)
BMI (kg/m2)
percent change
Blood pressure systolic and diastolic
change in blood pressure
physical activity questionnaire IPAQ
increase or decrease in number of minutes in vigorous and moderate activity and walking in walking time and activity.
International Physical Activity Prevalence Study SELF-ADMINISTERED ENVIRONMENTAL MODULE(PANES):
Questions 2,4,6,9,13,14 and 16 of PANES with be assessed
PHQ9 Depression score
Scores less than 5 almost always signified the absence of a depressive disorder; scores of 5 to 9 predominantly represented patients with either no depression or subthreshold (i.e., other) depression; scores of 10 to 14 represented a spectrum of patients; and scores of 15 or greater usually indicated major depression.
PAID-5 problem areas in diabetes
the scale gives a total score from 0 to 20. A score of 8 and above indicates a high level of diabetes-related distress
Self-care for diabetes (SDSCA)
. Responses are rated on a 5 point scale ranging from ''can't do at all'' to ''certain can do'' (1, 5). In this scale, higher scores indicate higher self-efficacy in perform- ing DSM activities.
modified joslin diabetes center CGM experience
Likert score 1-5 with higher score being positive
perception of behavior modification after CGM use
yes no questions about changes to activity or lifestyle with yes being positive
household/family member perception of lifestyle changes
household members perception of lifestyle changes after family member participated in education with or without CGM with individual yes or no questions with yes being positive
pedometer
average number of steps per day
The Neighborhood Questionnaire/Neighborhood Safety
a 16-item tool to assess sociability and an individual's satisfaction with the family's neighborhood. It has three subscales, and we will ask the Neighborhood Safety Subscale (items 1, 6, 10, 11, and 12) as a brief assessment of participants' ability to safely engage in physical activity in their neighborhoods
Self-Efficacy for Diabetes
the scale is 1-10 and the score is the mean of the eight items. If more than two items are missing, do not score the scale. Higher number indicates higher self-efficacy

Full Information

First Posted
April 19, 2022
Last Updated
September 27, 2023
Sponsor
University of Washington
Collaborators
American Diabetes Association, Washington State University, Sea Mar Community Health Centers, DexCom, Inc.
search

1. Study Identification

Unique Protocol Identification Number
NCT05394844
Brief Title
Diabetes Education With Real-time Continuous Glucose Monitoring
Acronym
CUTDM
Official Title
Pilot Study of a Culturally Tailored Diabetes Education Curriculum With Real-time Continuous Glucose Monitoring in a Latinx Population With Type 2 Diabetes (The CUTDM With CGM Study)
Study Type
Interventional

2. Study Status

Record Verification Date
September 2023
Overall Recruitment Status
Recruiting
Study Start Date
November 11, 2022 (Actual)
Primary Completion Date
June 30, 2024 (Anticipated)
Study Completion Date
November 30, 2024 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Washington
Collaborators
American Diabetes Association, Washington State University, Sea Mar Community Health Centers, DexCom, Inc.

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
Yes
Product Manufactured in and Exported from the U.S.
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
Determine the impact of the Compañeros en Salud (Partners in Health) curriculum in conjunction with RT-CGM on glycemic control in Latinx patients with T2D. Participants will be randomized to receive the Companeros en Salud diabetes self-management education and support (DSMES) intervention with or without RT-CGM
Detailed Description
The prevalence of type 2 diabetes is increasing especially in the Latinx community and in family members of those already living with diabetes. Diabetes education is a cornerstone of treatment but is often not culturally tailored and there is limited data on benefit of virtual delivery of sessions. Real Time Continuous glucose monitoring is a tool to improve diabetes but is not readily available to those living with type 2 diabetes not on multiple doses of insulin. Furthermore here is little to no data on RT-CGM use in different minority populations. Data is also lacking on if diabetes education for an individual affects the family unit. We hypothesize that culturally tailored Diabetes self-management education using and support (DSMES) using a team approach of health educators and Community health workers will improve glycemic indices. We further hypothesis that RT-CGM coupled to DSMES will enhances glycemic benefit and change nutrition and activity behaviors. This will be a randomized control trial of 100 Latinx participants who will all receive culturally tailored DSMES with or without cycle RT-CGM over 12 weeks. Primary outcome will be mean A1C improvement at 12 and 24 weeks based on attendance of sessions and RT-CGM use. Secondary outcomes will be satisfaction with education and CGM, changes in weight, blood pressure and self-reported nutrition and exercise changes. This study will be the first study to examine how DSMES with and without RT-CGM use improves health outcomes in the Latinx population and their families

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Diabetes Type 2
Keywords
continuous glucose monitoring, diabetes education

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Real Time Continuous Glucose Monitoring using Dexcom G6 and Diabetes education
Masking
InvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
100 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
CGM with DM education
Arm Type
Active Comparator
Arm Description
if you are in the intervention group you will received culturally tailored diabetes education and use a Real Time CGM device to see your glucose over 12 weeks. Both group will completed blinded CGM at the beginning of the study and at 24 weeks
Arm Title
Education only
Arm Type
No Intervention
Arm Description
If you are in the control group your will receive culturally tailored diabetes education and wear a blinded prior to education and after education sessions complete and 24 weeks
Intervention Type
Device
Intervention Name(s)
Dexcom G6
Other Intervention Name(s)
Compañeros en Salud (Partners in Health) curriculum
Intervention Description
Dexcom G6 CGM device
Primary Outcome Measure Information:
Title
A1C
Description
average glucose over 3 months
Time Frame
change at 12 and 24 weeks after education intervention
Secondary Outcome Measure Information:
Title
CGM mean glucose
Description
mean glucose
Time Frame
change at 12 and 24 weeks
Title
CGM percent time in range
Description
percent time in range( tir)
Time Frame
change at 12 and 24 weeks
Title
BMI (kg/m2)
Description
percent change
Time Frame
change at 12 and 24 weeks
Title
Blood pressure systolic and diastolic
Description
change in blood pressure
Time Frame
change at 12 and 24 weeks
Title
physical activity questionnaire IPAQ
Description
increase or decrease in number of minutes in vigorous and moderate activity and walking in walking time and activity.
Time Frame
12 and 24 weeks
Title
International Physical Activity Prevalence Study SELF-ADMINISTERED ENVIRONMENTAL MODULE(PANES):
Description
Questions 2,4,6,9,13,14 and 16 of PANES with be assessed
Time Frame
baseline
Title
PHQ9 Depression score
Description
Scores less than 5 almost always signified the absence of a depressive disorder; scores of 5 to 9 predominantly represented patients with either no depression or subthreshold (i.e., other) depression; scores of 10 to 14 represented a spectrum of patients; and scores of 15 or greater usually indicated major depression.
Time Frame
baseline
Title
PAID-5 problem areas in diabetes
Description
the scale gives a total score from 0 to 20. A score of 8 and above indicates a high level of diabetes-related distress
Time Frame
change at 12 and 24 weeks
Title
Self-care for diabetes (SDSCA)
Description
. Responses are rated on a 5 point scale ranging from ''can't do at all'' to ''certain can do'' (1, 5). In this scale, higher scores indicate higher self-efficacy in perform- ing DSM activities.
Time Frame
change at 12 and 24 weeks
Title
modified joslin diabetes center CGM experience
Description
Likert score 1-5 with higher score being positive
Time Frame
12 weeks
Title
perception of behavior modification after CGM use
Description
yes no questions about changes to activity or lifestyle with yes being positive
Time Frame
12 weeks
Title
household/family member perception of lifestyle changes
Description
household members perception of lifestyle changes after family member participated in education with or without CGM with individual yes or no questions with yes being positive
Time Frame
12 weeks
Title
pedometer
Description
average number of steps per day
Time Frame
change at 12 and 24 weeks
Title
The Neighborhood Questionnaire/Neighborhood Safety
Description
a 16-item tool to assess sociability and an individual's satisfaction with the family's neighborhood. It has three subscales, and we will ask the Neighborhood Safety Subscale (items 1, 6, 10, 11, and 12) as a brief assessment of participants' ability to safely engage in physical activity in their neighborhoods
Time Frame
baseline
Title
Self-Efficacy for Diabetes
Description
the scale is 1-10 and the score is the mean of the eight items. If more than two items are missing, do not score the scale. Higher number indicates higher self-efficacy
Time Frame
change at 12 and 24 weeks

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
60 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Participants adults 18-60 years old Self-identify as Latinx Have had a clinical diagnosis of T2D within the last 15 years with or without medication use Have an A1C ≥8.0% at screening Own or have routine access to a personal device that allows attending educational sessions virtually Be physically and cognitively able to use the home CGM monitoring device Be willing and able to follow all other study procedures Exclusion Criteria Exclusion Criteria. Duration of diabetes >15 years Type 1 diabetes or latent autoimmune diabetes Current use of prandial insulin Any condition that prevents walking at least 1 city block History of serious mental illness other than adequately treated depression History of bariatric surgery or current participation in a weight management program Current diagnosis of cancer or other serious or systemic medical condition Significant active cardio- or cerebrovascular disease after review by PI Pregnancy know history x of of hypoglycemia unawareness Unable to read, understand, and sign the Informed Consent Form (ICF) and if applicable, an Authorization to Use and Disclose Protected Health Information form (consistent with Health Insurance Portability and Accountability Act of 1996 [HIPAA] legislation), communicate with the investigator, and understand and comply with protocol requirements
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
nicole ehrhardt
Phone
2065208500
Email
nehrhard@uw.edu
Facility Information:
Facility Name
University of Washington Diabetes Institute
City
Seattle
State/Province
Washington
ZIP/Postal Code
98109
Country
United States
Individual Site Status
Recruiting
Facility Name
University of Washington
City
Seattle
State/Province
Washington
ZIP/Postal Code
98109
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
evelyn jones
Phone
206-221-9369
Email
LCGM@uw.edu

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Diabetes Education With Real-time Continuous Glucose Monitoring

We'll reach out to this number within 24 hrs